Political Upheaval Forces Medical Centers to Adapt
August 6, 2025
Academic medical centers are racing to adapt as political turnover and funding uncertainty threaten the future of cell and gene therapy research.
5 min read
False
Advertisement
2025
AI Reshaping Drug Discovery
August 6, 2025
Discussing the challenges and AI-based solutions in the earliest stages of drug development
4 min read
This Week’s CGT News: Adaptimmune Therapeutics to Restructure After Acquisition
August 6, 2025
Our latest news roundup reports on a new cell and gene facility in Germany, cell therapy grants, and results from a global pharmacovigilance study on malignancies following CAR T treatment
4 min read
An Oral Approach for Diabetic Retinopathy
August 5, 2025
How a small molecule drug originally developed for cardiac arrhythmia could become a non-invasive treatment option for diabetic retinopathy.
3 min read
Allogene Amends Phase II Cell Therapy Trial After Patient Death
August 5, 2025
The trial will continue, but development activities associated with a monoclonal antibody are to be discontinued.
1 min read
What’s Evaluated in a Stability Study?
August 5, 2025
Looking at the importance of stability programs in early clinical drug product development.
3 min read
Understanding the Role of TRPV1 in Small Molecule Treatments for Obesity and Diabetes
August 4, 2025
Step aside, GLP-1 biologics – there’s a smaller kid in town. Meet the clinical stage Nordic company developing a small molecule TRPV1 antagonist for weight loss and diabetes treatment.
8 min read
What Happened with Sarepta, Elevidys and Vinay Prasad?
August 4, 2025
FDA investigations, shipments holds, a resignation at the FDA and a negative opinion in Europe… I look into the recent controversy
5 min read
What’s Going on With Measles Outbreaks?
August 1, 2025
Cases of measles in the US and Europe are reaching record highs.
4 min read
This Week’s CGT News: Genethon’s Phase III Gene Therapy Trial
July 31, 2025
Our latest news roundup reports on Pierre Fabre’s FDA acceptance, CGT Catapult appointment, progress in Duchenne muscular dystrophy, and more.
4 min read
